Related Experiment Videos
Should we regard CA125 as the indication to treat relapsing ovarian cancer?
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Markers of tumor burden : an overview.
Methods in molecular medicine·2011
Ischaemic heart disease mortality study among workers with occupational exposure to ammonium perfluorooctanoate.
Occupational and environmental medicine·2009
Management of anaemia in patients with breast cancer: role of epoetin.
Annals of oncology : official journal of the European Society for Medical Oncology·2005
Locally advanced breast cancer: the outcome of primary polychemotherapy based on infusional 5 fluorouracil.
Breast (Edinburgh, Scotland)·2004
Bacterial endocarditis associated with a skin-tunnelled catheter.
Breast (Edinburgh, Scotland)·2004
Osteonecrosis of the femoral head following adjuvant chemotherapy for breast cancer.
Breast (Edinburgh, Scotland)·2004
Final results and predictive biomarkers of response and long-term outcomes with first-line pembrolizumab monotherapy in advanced renal cell carcinoma in the phase II KEYNOTE-427 study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Navigating uncertainties and evidence gaps in adjuvant therapy for premenopausal women with HR+/HER2- breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Safety and antitumor activity of the first-in-class EGFR-HER3 bispecific antibody-drug conjugate iza-bren (BL-B01D1) in patients with pretreated locally advanced or metastatic breast cancer: a phase 1b study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Adjuvant pembrolizumab for the treatment of clear cell renal cell carcinoma: five-year results from the phase III KEYNOTE-564 study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Thymic radiation is associated with worse outcomes in patients with NSCLC.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Sustained benefit of adjuvant olaparib in women with germline BRCA1- and BRCA2-associated high-risk HER2-negative early breast cancer: updated results from the OlympiA phase III trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2026